The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery-Reference-Cited by-同舟云学术

The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery

Published:2019-02 Issue: Volume:557 Page:273-279
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Wen Ziyi,Muratomi Natsuko,Huang Wei,Huang Liqun,Ren Jinfeng,Yang Jennifer,Persaud Yogeeta,Loloi Justin,Mallangada Naveen,Kung Preston,Honkanen Robert,Rigas Basil^ORCID

Funder

Stony Brook University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. A comprehensive insight on ocular pharmacokinetics;Agrahari;Drug Delivery Transl. Res.,2016

2. Biomedicine. A new angle on ocular development;Alward;Science,2003

3. Immunophenotyping of human dendriform cells from the conjunctival epithelium;Baudouin;Curr. Eye Res.,1997

4. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol;Budhian;J. Microencapsulation,2005

5. Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer;Cheng;Int. J. Oncol.,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico evaluation of corneal patch eluting anti-VEGF agents concept;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Resveratrol and lipoic acid: A promising combination for treating dry eye disease;Journal of Drug Delivery Science and Technology;2024-09

3. Unveiling the potential of bacterial cellulose-based composites in eye tissue engineering: a review;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-06-20

4. Pharmacological Potential of Sulindac and Its Active Metabolite: A Comprehensive Review;Current Drug Therapy;2023-10-24

5. Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies;Pharmaceutics;2023-10-04